Tudhope and colleagues tested the effects of serotonin (5-hydroxytryptamine [5-HT]) on postprandial hepatic glucose uptake. They found that 5-HT had both stimulatory and inhibitory effects on glycogen synthesis in hepatocytes, which were mediated by 5-HT1F/5-HT2A and 5-HT2B receptors, respectively. These opposing effects could underlie the hyperglycemia or hypoglycemia caused by drugs targeting serotonin function, suggest the investigators.